Our fully-human biologic drug platform combines RNases and DNases with an antibody Fc to remove extracellular nucleic acids including RNA, DNA and neutrophil extracellular traps (NETs), which restores homeostasis and resolves inflammation. We are applying this technology across multiple acute and chronic diseases with high unmet need.